Cameco (CCJ US)

CCJ US$71.68

20 minute delayed

Today ▼ -1.21%

1 year return ▼ -26.06%

Volume 863,243

Div yield 0.24%

PE ratio 110.00

52 week range

69.64 131.10

14 days free access

Join Market Matters and get full access to all our Opinion + Action

Learn more

Performance

Share price activity

Last (Price): 71.68
Change: ▼ -0.88 (-1.21)
Bid / Ask: 71.67 - 71.69
Volume: 863,243
Turnover: 35,992,624
Open: 72.83
Day Range: 69.59 - 73.33
VWAP: 71.41
Prev Close: 72.56
Last Trade: 04/11 7:00pm

Key information

Sector: Energy
Shares Issued: 435,532,978
NTA/Share: 15.77
Last Dividend: 0.24
Dividend Ex Date: 1 DEC 2025
Dividend Pay Date: 16 DEC 2025

Current (CAD) · FY2025

Revenue: 3,481.93
EBITDA: 1,150.91
Profit: 589.58
Earnings Per Share (EPS): 1.35
Dividend Per Share (DPS): 0.24
Yield %: 0.24
Market Cap: 31,219.00
Price to Earnings Ratio (P/E): 110.00

Estimates (CAD) · FY2027

Revenue: 3,687.95
EBITDA: 2,557.30
Profit: 1,045.20
Earnings Per Share (EPS): 2.40
Dividend Per Share (DPS): 0.24

Quantitative rating

Overvalued

Economic Moat: Narrow
Financial Health: Moderate
Uncertainty: Very High

Morningstar Quantitative Rating as of 4 NOV 2026.

Quantitative Equity Rating Methodology – view here

Fair value estimate

Five-star price 41.11 Fair value 59.42 One-star price 85.87

Morningstar Quantitative Rating as of 4 NOV 2026.

Quantitative valuation

Buy Sell

Fair Value: 59.42
Price / Fair Value: 1.21
Valuation: Overvalued
Uncertainty: Very High

Morningstar Quantitative Rating as of 4 NOV 2026. The slider runs from the five-star price (41.11) to the one-star price (85.87).

Ratios
Currency (Price/reporting): USD/CAD
Exchange Rate: 0.7160

Price - closing or last bid	72.56
Price - 12 month high	131.10
Price - 12 month low	71.86
Pricing date	3 NOV 2026
Volume - avg. trading volume for the last ten days	3.58
Market capitalization	31,219.00
12 Month High price date	23 APR 2026
12 Month Low price date	3 NOV 2026
Volume - avg. trading volume for the last 3 months	3.10
Price - 1 Day % Change	-1.12%
Price - 13 week price percent change	-19.13%
Price - 26 week price percent change	-39.83%
Price - 5 Day % Change	-11.95%
Price - 52 week price percent change	-28.05%
Price - YTD price percent change	-20.59%
Price % Change Month To Date	-14.82%

EPS excluding extraordinary items - most recent fiscal year	1.350
EPS excluding extraordinary items - trailing 12 month	0.910
EPS Normalized - most recent fiscal year	1.439
Revenue/share - most recent fiscal year	7.994
Revenue/share - trailing 12 month	7.986
Book value per share - most recent fiscal year	15.853
Book value per share - most recent quarter	16.609
Book value (tangible) per share - most recent fiscal year	15.770
Book value (tangible) per share - most recent quarter	16.532
Cash per share - most recent fiscal year	2.560
Cash per share - most recent quarter	1.974
Cash Flow per share - most recent fiscal year	2.568
Cash Flow per share - trailing 12 month	1.886
Dividend per share - most recent fiscal year	0.240
Dividends per share - trailing 12 month	0.174
EBITD per share - trailing 12 month	1.974
EPS Basic excluding extraordinary items - most recent fiscal year	1.350
EPS Basic excluding extraordinary items - trailing 12 month	0.910
EPS including extraordinary items - most recent fiscal year	1.350
EPS including extraordinary items - trailing 12 month	0.910
Free Cash Flow per share - trailing 12 month	0.898

P/E excluding extraordinary items, most recent fiscal year	109.33
P/E Normalized, most recent fiscal year	87.27
Price to sales - most recent fiscal year	12.46
Price to Tangible Book - most fiscal year	6.15
Price to Free Cash Flow per Share - most recent fiscal year	110.79
Price to Cash Flow per share - trailing 12 month	52.74
Price to Book - most recent fiscal year	6.12
P/E excluding extraordinary items high, trailing 12 months	183.28
P/E excluding extraordinary items low, trailing 12 months	78.47
Net Debt, LFI	137.13
Net Debt, LFY	-218.12
Dividend Yield - 5 Year Average	0.21%
Dividend Yield - indicated annual dividend divided by closing price	0.24%
Current Dividend Yield - Common Stock Primary Issue, LTM	0.24%

Free Cash Flow - most recent fiscal year	785.73
LT debt/equity - most recent fiscal year	14.43%
Payout ratio - most recent fiscal year	17.78%
Total debt/total equity - most recent fiscal year	14.43%
LT debt/equity - most recent quarter	13.78%
Total debt/total equity - most recent quarter	13.78%
Free Cash Flow - trailing 12 month	391.19
Payout ratio - trailing 12 month	26.37%

Revenue - most recent fiscal year	3,481.93
Revenue - trailing 12 month	3,479.13
EBITD - most recent fiscal year	1,150.91
EBITD - trailing 12 month	860.08
Earnings before taxes - most recent fiscal year	777.26
Earnings before taxes - trailing 12 month	509.74
Net Income available to common - most recent fiscal year	589.58
Net Income available to common - trailing 12 months	397.75
Earnings before taxes Normalized - most recent fiscal year	706.02
Net Income Available to Common, Normalized - most recent fiscal year	627.00
Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM	1.14

Net Profit Margin % - 1st historical fiscal year	16.93%
Net Profit Margin % - trailing 12 month	11.43%
Operating margin - 1st historical fiscal year	17.84%
Operating margin - trailing 12 month	14.06%
Pretax margin - trailing 12 month	14.65%
Pretax margin - 1st historical fiscal year	22.32%
Operating Margin - 5 year average	7.69%
Pretax Margin - 5 year average	9.37%
Free Operating Cash Flow/Revenue, 5 Year Average	15.75%
Free Operating Cash Flow/Revenue, TTM	11.24%
Net Profit Margin - 5 year average	6.83%

Return on average assets - most recent fiscal year	6.03%
Return on average assets - trailing 12 month	3.91%
Return on average equity - most recent fiscal year	8.86%
Return on average equity - trailing 12 month	5.66%
Return on average assets - 5 year average	2.71%
Return on average equity - 5 year average	4.00%
Net Income/employee - most recent fiscal year	191,285.53
Revenue/employee - most recent fiscal year	1,129,764.11

Revenue growth rate, 5 year	14.11%
EPS growth rate, 5 year	—
Growth rate% - dividend, 3 year	25.99%
Revenue/share (5 yr growth)	11.94%
Growth rate% - Revenue, 3 year	23.07%
Growth rate% - EPS, 3 year	83.08%
Book value per share growth rate, 5 year	4.85%
Capital Spending growth rate, 5 year	33.87%
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR	39.73%

Financial forecast (CAD, millions except per share)

	Actuals	Estimates
	2025	2026	2027	2028

Financials (CAD, millions)

Period end:	DEC 21	DEC 22	DEC 23	DEC 24	DEC 25
Fiscal year:	2021	2022	2023	2024	2025
Period length:	12 months	12 months	12 months	12 months	12 months

Announcements

Announcements are available for ASX-listed companies only.

Opinion

25/08/2026 09:26

Cameco Corp (CCJ US) US$102.27

CCJ is a US$44bn uranium giant CCJ which is more than 10x larger than local player Paladin (PDN). CCJ like many in the sector has endured a volatile 2026, with CCJ and the URNM ETF peaking and bottoming at almost identical times, although CCJ has modestly outperformed the ETF YTD thanks to its scale, diversified operations and exposure to Westinghouse. The January rally was fuelled by enthusiasm around nuclear power, AI-driven electricity demand and uranium contracting, while a C$2.6bn supply agreement with India in March reinforced the longer-term demand story.

03/08/2026 09:38

Cameco Corp (NYSE: CCJ) $US86.38

Cameco delivered a weaker-than-expected second quarter update on Friday, with earnings and revenue missing forecasts as uranium production was disrupted by difficult spring road conditions in northern Saskatchewan and earnings from Westinghouse fell sharply.

06/05/2026 09:13

Cameco (CCJ US) $US114.46

A strong March-quarter result from Cameco, with the uranium producer beating expectations across earnings, revenue, production and gross profit. The result was driven by higher uranium sales volumes, a better average realised uranium price and a growing contribution from Westinghouse, reinforcing the broader investment case around nuclear energy and long-term uranium demand. Management also maintained FY26 guidance, which we thought would have been taken positively, and it was initially, however the stock reversed lower throughout the session to finish down -3.2%.

22/01/2026 09:40

Cameco Corp (CCJ US) $US122.33

Cameco is the world’s largest publicly traded uranium producer, headquartered in Canada, supplying uranium fuel to nuclear utilities globally, with flagship assets including Cigar Lake and McArthur River/Key Lake in Saskatchewan. Its market cap is more than 10x that of PDN.

06/11/2025 09:26

Cameco Corp (CCJ US) $US96.00

Canadian uranium giant Cameco slipped ~1% overnight after its third-quarter revenue missed estimates, although earnings still rose as the company reaffirmed FY25 sales guidance of $US3.3-3.55bn.

29/10/2025 09:37

Cameco Corp (CCJ US) $US106.82

Uranium stocks surged higher overnight on the news that Westinghouse Electric (49% owned by CCJ) had secured a major contract with the US government to build new nuclear reactors.

23/10/2025 09:49

Cameco Corp (CCJ US) $US84.49

Energy is a huge requirement to drive AI, and as usage expands, AI data centres are projected to consume city-scale power levels, potentially reaching 4% of global electricity use by 2030.

01/08/2025 09:32

Cameco Corp (CCJ US)$US74.93

The largest listed western uranium producer, CCJ, slipped overnight after opening stronger following its earnings report. Still, it succumbed to market weakness, plus its +230% appreciation from its April low, which probably led to some understandable profit taking.

02/07/2025 15:24

International Equities Portfolio – Amendment

We are trimming Cameco (CCJ US)

26/05/2025 09:21

Chart of the Week – Cameco Corp (CCJ US)

This $US25bn US uranium stock puts the ASX sector to shame. It's about to make new highs while local names languish in ugly bear markets—at least for now. Following President Trump's commentary, we believe the US is going to push ever harder into nuclear power, driving up stocks like CCJ in the process.

Action

Updated 03/08/2026 09:19

CCJ US

Updated 03/08/2026 09:19

MM remains long & bullish CCJ US

Updated 06/05/2026 10:31

CCJ US

Updated 06/05/2026 10:31

MM remains long & bullish CCJ US ~$US115

Read the opinion

Updated 06/11/2025 09:50

CCJ US

Updated 06/11/2025 09:50

MM remains long & bullish Cameco

Read the opinion

Updated 29/10/2025 10:20

CCJ US

Updated 29/10/2025 10:20

MM remains long and bullish towards Cameco (CCJ US)

Read the opinion

Updated 23/10/2025 09:08

CCJ US

Updated 23/10/2025 09:08

MM is long and bullish on CCJ in its International Equities Portfolio

Updated 07/07/2025 09:34

CCJ US

Updated 07/07/2025 09:34

MM are trimming CCJ US in the International Equities Portfolio, targeting a 4% portfolio weighting ~$US71

Read the opinion

Updated 27/05/2025 09:58

CCJ US

Updated 27/05/2025 09:58

MM is bullish on Cameco (CCJ US), looking for new highs through 2025

Read the opinion

Updated 13/05/2025 10:29

CCJ US

Updated 13/05/2025 10:29

MM is long and bullish Cameco

Read the opinion

Updated 01/05/2025 09:38

CCJ US

Updated 01/05/2025 09:38

MM is long and bullish Cameco

Read the opinion

Updated 21/02/2025 17:29

CCJ US

Updated 21/02/2025 17:29

We remain long and bullish CCJ US

Read the opinion

Business Summary

Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe and is one of those uranium producers. It has three reportable segments: Uranium, Fuel Services, and Westinghouse, deriving maximum revenue from the Westinghouse segment. The Uranium segment involves the exploration for, mining, milling, purchase, and sale of uranium concentrate, while the Fuel Services segment involves the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. Westinghouse Electric Company provides products and services to nuclear reactors, including outage and maintenance services, engineering support, instrumentation and controls equipment, plant modification, and components and parts.